Clinical Trial/Study

he Sapien 3 heart valve (Edwards Lifesciences) demonstrated lower death, stroke and paravalvular leak rates than earlier generation devices in patients at high risk for surgery and showed encouraging results in intermediate-risk patients, accordin...

BEST trial, ACC.15,

Despite the advent of a new generation of stents, patients with multiple narrowed arteries in the heart who received coronary artery bypass grafting fared better than those whose arteries were opened with balloon angioplasty and stents in a study...

A new study published online in the journal Radiology found a substantial gap between patient expectations and current practices for providing information about medical imaging tests that use radiation. Researchers said the findings highl...

Results of a clinical trial announced at the American College of Cardiology Annual Scientific Session show a new type of therapy is safe and effective for symptomatic advanced heart failure patients already receiving optimum drug and dev...

Edwards Lifesciences, Sapien 3, Partner, ACC.15, acc 2015
he Sapien 3 heart valve (Edwards Lifesciences) demonstrated lower death, stroke and paravalvular leak rates than earlier generation devices in patients at high...
Patients who experience the deadliest form of heart attack — ST-segment elevation myocardial infarction (STEMI) — and suffer from substantial narrowing in...
BEST Trial
Despite the advent of a new generation of stents, patients with multiple narrowed arteries in the heart who received coronary artery bypass grafting fared...
A novel therapy that would allow doctors to turn the body’s blood clotting ability off and on in a more controlled way was about as effective as established...
Covidien DEFINITIVE LE Study Peripheral Artery Disease
The Solitaire Flow Restoration Device from Covidien is among a new generation of devices designed to remove blood clots from blocked brain...
Tilda, Vigila and Celerity leads offer a complete package for physicians to better manage their patients’ individualized needs. Tilda...
The U.S. Food and Drug Administration (FDA) in April 2012 approved an expanded indication for Medtronic’s cardiac resynchronization therapy...

Articles

Edwards Lifesciences, Sapien 3, Partner, ACC.15, acc 2015
he Sapien 3 heart valve (Edwards Lifesciences) demonstrated lower death, stroke and paravalvular leak rates than earlier generation devices in patients at high...
BEST Trial
Despite the advent of a new generation of stents, patients with multiple narrowed arteries in the heart who received coronary artery bypass grafting fared...
A novel therapy that would allow doctors to turn the body’s blood clotting ability off and on in a more controlled way was about as effective as established...
atients with atrial fibrillation (AF) who received ablation while they were already undergoing surgery to correct a leaky mitral valve had fewer...

Video Center

The biggest technology news coming out of the 2015 American College of Cardiology (ACC) annual...
10 hours 21 min ago
It’s been no secret that the American healthcare system needed to change to survive economically...
6 weeks 14 hours ago
The silence is deafening. And since radiology associations, physician groups and vendors have yet...
8 weeks 17 hours ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...

Comparison Charts

Sorry there is no data available